A dataset of 200 structured product labels annotated for adverse drug reactions.
A dataset of 200 structured product labels annotated for adverse drug reactions.
复制标题
DOI:
10.1038/sdata.2018.1
复制
发表时间:
2018-01-30
期刊:
影响因子:
9.8
通讯作者:
Tonning J
中科院分区:
文献类型:
--
作者:
Demner-Fushman D;Shooshan SE;Rodriguez L;Aronson AR;Lang F;Rogers W;Roberts K;Tonning J
Adverse drug reactions (ADRs), unintended and sometimes dangerous effects that a drug may have, are one of the leading causes of morbidity and mortality during medical care. To date, there is no structured machine-readable authoritative source of known ADRs. The United States Food and Drug Administration (FDA) partnered with the National Library of Medicine to create a pilot dataset containing standardised information about known adverse reactions for 200 FDA-approved drugs. The Structured Product Labels (SPLs), the documents FDA uses to exchange information about drugs and other products, were manually annotated for adverse reactions at the mention level to facilitate development and evaluation of text mining tools for extraction of ADRs from all SPLs. The ADRs were then normalised to the Unified Medical Language System (UMLS) and to the Medical Dictionary for Regulatory Activities (MedDRA). We present the curation process and the structure of the publicly available database SPL-ADR-200db containing 5,098 distinct ADRs. The database is available at https://bionlp.nlm.nih.gov/tac2017adversereactions/; the code for preparing and validating the data is available at https://github.com/lhncbc/fda-ars.
登录
查看更多内容
DOI:
10.1093/database/bav016
发表时间:
2015-03-22
影响因子:
5.8
作者:
Khare, Ritu;Burger, John D.;Lu, Zhiyong
通讯作者:
Lu, Zhiyong
影响因子:
14.9
作者:
Cai MC;Xu Q;Pan YJ;Pan W;Ji N;Li YB;Jin HJ;Liu K;Ji ZL
通讯作者:
Ji ZL
DOI:
10.1197/jamia.m1733
发表时间:
2005-05-01
影响因子:
6.4
作者:
Hripcsak, G;Rothschild, AS
通讯作者:
Rothschild, AS
影响因子:
4.5
作者:
South BR;Mowery D;Suo Y;Leng J;Ferrández Ó;Meystre SM;Chapman WW
通讯作者:
Chapman WW
影响因子:
14.9
作者:
Kuhn M;Letunic I;Jensen LJ;Bork P
通讯作者:
Bork P